Trial Profile
A Study to Evaluate the Efficacy and Safety of S-1 and Cisplatin with Concurrent Thoracic Radiotherapy in Patients with Loacally Advanced Non-Small Cell Lung Cancer (NSCLC)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 07 Dec 2015 New trial record